Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASH.L Regulatory News (ASH)

  • There is currently no data for ASH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed CVA and potential Reverse Takeover

30 Jul 2020 12:25

RNS Number : 6429U
Ashley House PLC
30 July 2020
 

Ashley House plc

 

Proposed Company Voluntary Arrangement and potential Reverse Takeover

 

Ashley House plc ("Ashley House" or the "Company") announces that it has filed a Company Voluntary Arrangement ("CVA") proposal and is in discussions for the Company to potentially combine with Piper Homes plc ("Piper"), an unlisted Midland based housing developer, by way of a Reverse Takeover or similar transaction.

Background

On 6 March 2020, the Company announced that, due to the material uncertainty of the Company's current financial condition, trading in the Company's shares on both AIM and NEX was suspended from that date. Trading in the Company's shares on NEX was withdrawn on 26 March 2020.

Since that date, the Company has explored many options to raise further funding and corporate opportunities to meet its ongoing working capital commitments and to support its affordable housing strategy. This included the administration of the Company's 76% subsidiary, F1 Modular Limited, as announced on 30 March 2020 and the sale of its interests in Partnering Health Limited and Infracare LIFT Holdings Limited as announced on 7 May 2020.

Despite its best efforts, the Company has been unable to raise further funds with the COVID-19 pandemic seriously restricting the Company's ability to do so.

For the last two months, the Company has been discussing a potential transaction with Piper. The discussions have been wide ranging but have included, amongst other structures, whether Piper could potentially obtain a listing through a Reverse Takeover of the Company pursuant to AIM Rule 14 or another similar transaction (the "Proposed Transaction").

Company Voluntary Arrangement

In order to allow the Company to pursue a future corporate strategy and avoid administration or liquidation and to achieve the best result possible from the current position for creditors, shareholders and other stakeholders, the Board believes that it is in the best interests of the Company to enter into the following arrangements:

· Documentation has been filed in the High Court and will today be dispatched to the creditors of the Company, together with a notice convening a Creditors' Meeting, the purpose of which is to consider the Directors' proposal for a CVA, subject to shareholder approval;

· The Company has engaged Begbies Traynor (Central) LLP to act as Nominee and Supervisor for the CVA;

· Piper Homes plc has paid £50,000 to Ashley House to fund the initial costs of pursuing the proposals, with a further £50,000 payable once the CVA has been approved and the 28 day challenge period has passed; and

· The Company is issuing today a Circular to shareholders ("Circular") setting out the background to the CVA and seeking shareholders' approval for it. Notice convening a General Meeting to be held on 18 August 2020, to consider and, if thought fit, approve a Resolution giving this approval, is set out at the end of the Circular.

The CVA will not result in any distribution being made to existing members in their capacity as shareholders.

Based upon discussions to date, shareholders should be aware that, in any Proposed Transaction, the value attributable to the equity in Ashley House is likely to be minimal, albeit it is anticipated that shareholders would have some further opportunity to participate in the enlarged group through a subscription warrant structure. Further details will be provided in due course.

Any Proposed Transaction with Piper is conditional upon:

(i) the approval of the CVA both by shareholders and by the Company's creditors; and

(ii) the passing in due course at a General Meeting of resolutions to approve the Proposed Transaction, the grant of authority to allot new shares in connection with such transaction and waiver by the Takeover Panel of the mandatory offer requirement which would otherwise arise from such allotment.

If either of the above conditions are not satisfied, then the Proposed Transaction will not proceed and, since the Company would have insufficient working capital to continue to trade, the Directors would likely have no alternative but to place the Company immediately into administration or liquidation. There can be no certainty that the Proposed Transaction will proceed or as to the terms of any Proposed Transaction.

Report and Accounts Update

The Company's reporting deadline for the publication of its annual audited accounts for the period ended 31 October 2019 has been extended to 31 July 2020 as a result of the COVID-19 pandemic. The Company will not now be in a position to publish its accounts by this date. The results for the eighteen month period to 31 October 2019 will show a significant loss.

As stated above, the shares of the Company were suspended from trading on AIM on 6 March 2020 as a result of material financial uncertainty. In order to complete the Proposed Transaction, the Company would need to seek from the London Stock Exchange permission to extend beyond 6 September 2020 the period during which its shares remain suspended and should it do so, such permission may or may not be forthcoming. However, the Company and Piper in any case continue to explore alternative means to deliver a similar commercial outcome and will update shareholders in due course.

The Company again thanks its lenders, creditors, shareholders and all stakeholders for their continued patience and support in this difficult time.

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Not for release, publication or distribution, in whole or in part, directly or indirectly in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.

 

Enquiries:

Ashley House plc 01628 600 340

Antony Walters

Jonathan Holmes

James Hathaway

 

WH Ireland 0207 220 1666

(Nominated Adviser and Broker)

Adrian Hadden

James Sinclair-Ford

Darshan Patel

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAFXEDAAEEFA
Date   Source Headline
12th Dec 20134:36 pmRNSHolding(s) in Company
10th Dec 20137:00 amRNSInterim report 2013
30th Sep 20133:45 pmRNSShare Options
12th Sep 20131:42 pmRNSHolding(s) in Company
11th Sep 20134:56 pmRNSHolding(s) in Company
10th Sep 20137:00 amRNSDirector Dealings
27th Aug 20131:52 pmRNSAppointment of Chairman
29th Jul 201310:56 amRNSResult of AGM
5th Jul 20137:00 amRNSPosting of Annual Report & Notice of AGM
25th Jun 20137:00 amRNSPreliminary Results
14th Jun 20137:00 amRNSHolding(s) in Company
12th Jun 20137:00 amRNSAppointment as Asset Manager and Sale of Projects
6th Jun 201310:00 amRNSAdmission as Member of the Social Stock Exchange
28th May 20133:16 pmRNSHolding(s) in Company
10th May 20137:00 amRNSTrading update, Board review and strategy progress
19th Apr 20133:44 pmRNSHolding(s) in Company
9th Apr 20133:40 pmRNSDirectorate Change
18th Mar 20134:53 pmRNSChange of Registered Office
11th Mar 20133:09 pmRNSDirectorate Changes
11th Feb 20131:26 pmRNSHolding(s) in Company
22nd Jan 20137:00 amRNSNominated Advisor & Broker / Report & Accounts
18th Dec 20127:00 amRNSInterim Results
20th Nov 201211:53 amRNSHolding(s) in Company
29th Oct 201212:42 pmRNSResult of AGM and statement
20th Sep 20127:00 amRNSReport and Accounts
25th Jul 20127:05 amRNSHolding(s) in Company
25th Jul 20127:00 amRNSPreliminary Results
11th Jun 20123:58 pmRNSHolding(s) in Company
7th Jun 201211:36 amRNSNotice of Results & Trading Update
29th May 201212:13 pmRNSDirectorate Change
1st May 20123:12 pmRNSTrading Update
25th Apr 201212:02 pmRNSDirector/PDMR Shareholding
12th Apr 20123:39 pmRNSDirector/PDMR Shareholding
21st Feb 20127:00 amRNSInterim Report and Accounts
9th Feb 20128:17 amRNSHolding(s) in Company
7th Feb 201211:18 amRNSDirector/PDMR Shareholding
31st Jan 20127:00 amRNSInterim Report 2011
28th Nov 20112:46 pmRNSBoard Changes
31st Oct 201110:06 amRNSReport and Accounts
24th Oct 201111:54 amRNSResult of AGM and Statement
8th Sep 201111:28 amRNSHolding(s) in Company
26th Jul 20112:51 pmRNSHolding(s) in Company
26th Jul 20117:00 amRNSFinal Results
13th May 20117:00 amRNSTrading Update and Notice of Results
14th Apr 20119:42 amRNSHolding(s) in Company
29th Mar 20114:18 pmRNSHolding(s) in Company
17th Mar 20114:14 pmRNSExercise of Options
17th Mar 20117:00 amRNSHolding(s) in Company
7th Mar 20117:00 amRNSReceipt of Assura monies and Special Interim Divi
18th Feb 201112:00 pmRNSResponse to Assura statement re AH Medical

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.